The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis
Open accessAbstract
Mastocytosis is a hematopoietic neoplasm characterized by expansion of KIT D816V-mutated clonal mast cells in various organs and severe or even life-threatening anaphylactic reactions. Recently, hereditary α-tryptasemia (HαT) has been described as a common genetic trait with increased copy numbers of the α-tryptase encoding gene, TPSAB1, and associated with an increased basal serum tryptase level and a risk of mast cell activation. The purpose of our study was to elucidate the clinical relevance of HαT in patients with mastocytosis. TPSAB1 germline copy number variants were assessed by digital polymerase chain reaction in 180 mastocytosis patients, 180 sex-matched control subjects, 720 patients with other myeloid neoplasms, and 61 additional mastocytosis patients of an independent validation cohort. α-Tryptase encoding TPSAB1 copy number gains, compatible with HαT, were identified in 17.2% of mastocytosis patients and 4.4% of the control population (P < .001). Patients with HαT exhibited higher tryptase levels than patients without HαT (median tryptase in HαT+ cases: 49.6 ng/mL vs HαT− cases: 34.5 ng/mL, P = .004) independent of the mast cell burden. Hymenoptera venom hypersensitivity reactions and severe cardiovascular mediator-related symptoms/anaphylaxis were by far more frequently observed in mastocytosis patients with HαT than in those without HαT. Results were confirmed in an independent validation cohort. The high prevalence of HαT in mastocytosis hints at a potential pathogenic role of germline α-tryptase encoding TPSAB1 copy number gains in disease evolution. Together, our data suggest that HαT is a novel emerging robust biomarker in mastocytosis that is useful for determining the individual patient´s risk of developing severe anaphylaxis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is a consensus that HαT is a risk modifier of severe anaphylaxis [21,48,49,50,51,52,53].”
From Diagnostic Significance of Tryptase for Suspected Mast Cell Disorders (2023) · cites this paper as [51]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In patients with systemic mastocytosis (SM), the risk for developing severe or even life-threatening anaphylaxis is high, especially when a concomitant IgE-dependent allergy or the genetic trait Hereditary a -tryptasemia (H a T) is present.”
From Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review (2021) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, an approximately two to three times higher prevalence of H a T has been reported in two large cohorts of SM patients 25,129 ; also, H a T concurrently occurring with MCAS has been reported. 130,131”
From Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review (2021) · cites this paper as [25]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Further, H a T may be associated with an increased severity of anaphylactic reactions and other mediator-induced symptoms in patients with mastocytosis and venom allergy. 25,129”
From Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review (2021) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“in patients with SM, where it can reach up to 12%–20% (17, 19, 22, 23).”
From Defining “Normal” basal serum tryptase levels: a context-dependent approach to improve diagnostics in systemic mastocytosis (2025) · cites this paper as [22]
In the citing paper
“HαT is enriched in patients with SM,42,43 in Hymenoptera-allergic patients with severe anaphylaxis,44,45 and in patients with idiopathic anaphylaxis.42,43,45,46”
From Mast cell activation syndrome: Current understanding and research needs (2024) · cites this paper as [43]
In the citing paper
“Furthermore, MCAS has been reported in patients with hereditary a-tryptasemia (HaT), an autosomal dominant genetic trait caused by an increased copy-number of the atryptase gene TPSAB1, resulting in increased baseline serum tryptase levels.7,8”
From Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders (2024) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
Diagnostic criteria and classification of mastocytosis: a consensus proposal
Valent, P., Horny, H., Escribano, L., Longley, B. J., Li, C. Y., Schwartz, L. B., Marone, G., Núñez, R., Akin, C., Sotlar, K., et al. (2001) · Leukemia Research · doi:10.1016/s0145-2126(01)00038-8 · Cited by 1,114
Self-citationNagata, H., Worobec, A. S., Oh, C. K., Chowdhury, B. A., Tannenbaum, S. H., Suzuki, Y., & Metcalfe, D. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10560 · Cited by 871
Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis
Schwartz, L. B., Metcalfe, D. D., Miller, J. S., Earl, H., & Sullivan, T. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706253162603 · Cited by 784
Valent, P., Akin, C., Escribano, L., Födinger, M., Hartmann, K., Brockow, K., Castells, M., Sperr, W. R., Kluin‐Nelemans, H. C., Hamdy, N. A. T., et al. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01807.x · Cited by 750
Self-citationMastocytosis: 2016 updated WHO classification and novel emerging treatment concepts
Valent, P., Akin, C., & Metcalfe, D. D. (2016) · Blood · doi:10.1182/blood-2016-09-731893 · Cited by 698
Self-citationValent, P., Akin, C., Arock, M., Brockow, K., Butterfield, J. H., Carter, M. C., Castells, M., Escribano, L., Hartmann, K., Lieberman, P., et al. (2012) · International Archives of Allergy and Immunology · doi:10.1159/000328760 · Cited by 654
Self-citationLongley, B. J., Tyrrell, L., Lu, S.-Z., Ma, Y., Langley, K., Ding, T.-G., Duffy, T. P., Jacobs, P., Tang, L. H., & Modlin, I. M. (1996) · Nature Genetics · doi:10.1038/ng0396-312 · Cited by 606
Brockow, K., Jofer, C., Behrendt, H., & Ring, J. (2008) · Allergy · doi:10.1111/j.1398-9995.2007.01569.x · Cited by 523
Mast Cells, Mastocytosis, and Related Disorders
Theoharides, T. C., Valent, P., & Akin, C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1409760 · Cited by 518
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–190 of 190
Alheraky, A., Wierenga, A. T. J., Simpelaar, A., Hesp, L. B., Minović, I., Bagheri, N., Roozendaal, C., Span, L. F. R., Elberink, H. N. G. O., Kema, I. P., et al. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad206 · Cited by 7
Zama, D., Muratore, E., Giannetti, A., Neri, I., Conti, F., Magini, P., Ferrari, S., & Pession, A. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.716786 · Cited by 7
Anaphylaxis in Risky Populations
Gelincik, A. A., & Beyaz, Ş. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612829666221207105214 · Cited by 7
A high prevalence of hereditary alpha‐tryptasemia in pediatric mastocytoma
Madrange, M., Rossignol, J., Devin, C. J., Bekel, L., Bellon, N., Welfringer‐Morin, A., Méni, C., Bonigen, J., Bataille, P., Burdet, C., et al. (2024) · Allergy · doi:10.1111/all.16185 · Cited by 7
Glover, S. C., Carlyle, A., & Lyons, J. J. (2021) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2021.12.008 · Cited by 7
Hereditary alpha tryptasemia: elevated tryptase, female sex, thyroid disorders, and anaphylaxis
Puxkandl, V., Aigner, S., Hoetzenecker, W., & Altrichter, S. (2024) · Frontiers in Allergy · doi:10.3389/falgy.2024.1461359 · Cited by 6
Svetina, M., Kunej, T., Korošec, P., & Rijavec, M. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09069-8 · Cited by 7
Anaphylaxis viewed by experts: unmet needs
Sala-Cunill, A., & Cardona, V. (2021) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000771 · Cited by 6
Alpha-Tryptase Overexpression as a Modifier of Mast Cell–Mediated Reactions
Korošec, P., González‐de‐Olano, D., & Lyons, J. J. (2025) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2025.10.018 · Cited by 6
CKBA suppresses mast cell activation via ERK signaling pathway in murine atopic dermatitis
Tong, J., Li, Y., Cai, X., Lou, F., Sun, Y., Wang, Z., Zheng, X., Zhou, H., Zhang, Z., Fang, Z., et al. (2023) · European Journal of Immunology · doi:10.1002/eji.202350374 · Cited by 5
Case Report: A family history of peanut allergy and hereditary alpha-tryptasemia
Chantran, Y., Renaudin, H., Arock, M., Guiddir, T., & Nemni, A. (2024) · Frontiers in Allergy · doi:10.3389/falgy.2023.1322117 · Cited by 6
Lim, J., Ross, D. M., Brown, A. L., Scott, H. S., & Hahn, C. N. (2024) · Leukemia Research · doi:10.1016/j.leukres.2024.107566 · Cited by 5
When allergies have no name: is idiopathic anaphylaxis driven by co-factors?
Elkhalifa, S., Elbashir, H., & Abuzakouk, M. (2024) · Frontiers in Allergy · doi:10.3389/falgy.2024.1468945 · Cited by 5
Ballul, T., Sabato, V., Valent, P., Hermine, O., Lortholary, O., Rossignol, J., Ballul, T., Sabato, V., Livideanu, C. B., Neuraz, A., et al. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.103043 · Cited by 6
Self-citationDecoding the intricacies of the mast cell compartment
Carter, M. C., & Metcalfe, D. D. (2021) · British Journal of Haematology · doi:10.1111/bjh.17714 · Cited by 5
Hoermann, G., Orfao, A., Lyons, J. J., Chantran, Y., Broesby‐Olsen, S., Sabato, V., & Arock, M. (2025) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2025.07.055 · Cited by 4
Self-citationManagement of Mastocytosis and Mast Cell Activation in Children
Carter, M. C., Lange, M., Álvarez‐Twöse, I., Renke, J., Morales‐Cabeza, C., Caligaris, H., & Hartmann, K. (2025) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2025.11.016 · Cited by 4
Lyons, J. J. (2024) · Allergy and Asthma Proceedings · doi:10.2500/aap.2025.46.240088 · Cited by 5
Allergie au venin d’hyménoptère, désordres mastocytaires clonaux et alpha-tryptasémie héréditaire
Chatain, C., & van der Brempt, X. (2021) · Revue française d'allergologie · doi:10.1016/j.reval.2021.10.007 · Cited by 4
Galeas‐Pena, M., Lyons, J. J., Llivichuzhca-Loja, D., Everman, S., Yaghi, G., White, K., Sutradhar, S., Robinson, T. O., Owings, A. H., Dhaliwal, N. S., et al. (2026) · Frontiers in Allergy · doi:10.3389/falgy.2025.1726096 · Cited by 5
Mastocytosis: Part I: Pathogenesis, clinical presentation, and classification
Sizemore, J. A., Hansen, S., Moran, C. A., Petty, A. J., Rein, L. A. M., Jamison, M. O., & Nicholas, M. W. (2025) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2025.06.039 · Cited by 3
The evaluation, management, and future of indolent systemic mastocytosis
Syal, A., Toh, J., McInerney, A., & Tremblay, D. A. (2025) · Annals of Hematology · doi:10.1007/s00277-025-06475-y · Cited by 4
Pearls for practice from the 2023 joint task force anaphylaxis practice parameter
Maddukuri, C., Kartha, N., Conway, A. E., & Shaker, M. S. (2024) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000001397 · Cited by 4
Gotlib, J. R. (2021) · Blood · doi:10.1182/blood.2020008466 · Cited by 3
Crupi, F., Caroprese, J., & Mannelli, F. (2025) · Frontiers in Allergy · doi:10.3389/falgy.2025.1592001 · Cited by 2
Histopathology and Molecular Genetics in Systemic Mastocytosis: Implications for Clinical Management
Crupi, F., Sordi, B., Vanderwert, F. I., Gesullo, F., Amorosi, A., Mannelli, F., & Santi, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158772 · Cited by 2
Approach to Idiopathic Anaphylaxis in Adolescents
Conner, J. E., & Steinberg, J. A. (2023) · Medical Clinics of North America · doi:10.1016/j.mcna.2023.05.018 · Cited by 2
Hymenoptera anaphylaxis and mast cell activation disorders
González‐de‐Olano, D., & Álvarez‐Twöse, I. (2025) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000001088 · Cited by 2
Kranyak, A. C., Shuler, M. J., Williams, K. W., & Lee, L. W. (2022) · Pediatric Dermatology · doi:10.1111/pde.15160 · Cited by 2
Tryptase : un dosage, une formule, plusieurs indications
François, S., Collet, E., Nicaise‐Roland, P., & Chabane, H. (2022) · Revue française d'allergologie · doi:10.1016/j.reval.2022.03.011 · Cited by 2
Akin, C., & Chollet, M. B. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.08.012 · Cited by 2
Shared Transcriptomic Signatures of Inflammaging Among Diverse Strains of Drosophila melanogasterPreprint
Perna, S. I., Tang, W., Blimbaum, S., Li, A., & Zhou, L. J. (2024) · Research Square · doi:10.21203/rs.3.rs-4146509/v1 · Cited by 2
Rydz, A., & Lange, M. (2023) · Forum Dermatologicum · doi:10.5603/fd.96810 · Cited by 2
Predictors of Clonality and Underlying Mastocytosis in Mast Cell Activation Syndromes
González‐de‐Olano, D., & Álvarez‐Twöse, I. (2024) · Current Allergy and Asthma Reports · doi:10.1007/s11882-023-01122-w · Cited by 1
Točkova, O., Ručigaj, T. P., Ivančan, S., Bidovec‐Stojkovič, U., Rijavec, M., Šelb, J., & Korošec, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136023 · Cited by 1
Taumann, W., & Molderings, G. J. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1705201 · Cited by 1
Diagnosis, Prognostication, and Management of Patients With Mastocytosis: Status 2026
Valent, P., & Carter, M. C. (2026) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2025.10.042 · Cited by 2
Self-citationChernak, B. J., & Rampal, R. K. (2026) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2025.2604560 · Cited by 1
Valent, P., Hartmann, K., Stefanzl, G., Filik, Y., Bauer, K., Degenfeld‐Schonburg, L., Gleixner, K. V., Siebenhaar, F., Niedoszytko, M., Sperr, W. R., et al. (2026) · Current Allergy and Asthma Reports · doi:10.1007/s11882-026-01257-6 · Cited by 1
Self-citationWeiss, M., Rossignol, J., Campeotto, F., Foy, E., Elbany, C., Jaume, L., Geroux, L., Debeaupuis, O., Neuraz, A., Bekel, L., et al. (2026) · Pediatric Allergy and Immunology · doi:10.1111/pai.70373 · Cited by 1
Distinct roles of dopamine receptors in HIV latency reversal in a myeloid cell model
Basova, L. V., Riley, T., Delorme, V., de Siqueira-Lima, D., Milner, R., Ellis, R. J., Fox, H. S., & Marcondes, M. C. G. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1817754 · Cited by 1
Jiang, M., & Vadas, P. (2023) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2023.2203286 · Cited by 1
Management of Advanced Systemic Mastocytosis and Associated Myeloid Neoplasms
Tashi, T., & Deininger, M. W. (2023) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2023.04.009 · Cited by 1
Mimics of Allergy and Angioedema
Thomas, E. G., & Thomas, D. J. (2023) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2022.10.007 · Cited by 1
Hereditary alpha-tryptasemia and monoclonal mast cell disorders
Chantran, Y., & Arock, M. (2025) · Frontiers in Allergy · doi:10.3389/falgy.2025.1600680 · Cited by 1
Contemporary Grand Challenges and Opportunities in Skin Allergies
Wedi, B. (2021) · Frontiers in Allergy · doi:10.3389/falgy.2021.660447 · Cited by 1
Mimics of Allergy and Angioedema
Thomas, E. G., & Thomas, D. J. (2021) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2021.09.005 · Cited by 1
La previsión del futuro en la empresa
de Aizpuru, M. A. T. (1987) · Dialnet (Universidad de la Rioja) · Cited by 1
Polivka, L., & Bodemer, C. (2021) · Annales de Dermatologie et de Vénéréologie - FMC · doi:10.1016/j.fander.2021.05.006
Tryptase in all its states: From allergy to mastocytosis
Arock, M. (2022) · Revue française d'allergologie · doi:10.1016/j.reval.2022.01.004
A case of perioperative anaphylaxis presenting as hereditary alpha tryptasemia
Ritter, S., Bowden, J., & Pattanaik, D. (2022) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2022.03.011
Hereditary alpha-tryptasemia: Brief overview of current knowledge and proposal of indications
Chantran, Y., Hirsch, P., Stym‐Popper, G., Barète, S., & Arock, M. (2022) · Revue française d'allergologie · doi:10.1016/j.reval.2022.03.015
Evaluation and diagnosis of mast cell–associated disorders
Park, Y. H., & Lyons, J. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-95061-9.00020-5
Shared Transcriptomic Signatures of Inflammaging Among Diverse Strains of Drosophila melanogasterPreprint
Perna, S. I., Tang, W., Blimbaum, S., Li, A., & Zhou, L. J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.17.576061
Nouveaux critères diagnostiques des mastocytoses : des progrès mais encore des interrogations
Arock, M. (2024) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2024.03.009
A practical guide to recognize allergic and immunologic skin diseases: diagnosis at first sight
Cataudella, E., Perlato, M., Salvati, L., Agosta, E. D., Romaldi, A., Paolino, D., Ambrogio, F., Marietti, R., Magistà, S., Schettini, N., et al. (2024) · doi:10.37349/eaa.2024.00055
Mastocytosis and the Bone: Observational Study
Medio, L. D., Salerno, R., Mannelli, F., Crupi, F., Duradoni, M., Biagini, C., Lucibello, P., Vannucchi, A. M., & Brandi, M. L. (2024) · Endocrinology · doi:10.1007/978-3-030-19632-5_23-1
Worm, M., Brockow, K., Hartmann, K., Treudler, R., & Wedi, B. (2025) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2024.0124
Hereditary Alpha Tryptasemia: Survey of Concomitant Genetic Testing
Butterfield, J. H., Bhasin, A. K., Ishmael, L., & Squire, J. D. (2025) · International Archives of Allergy and Immunology · doi:10.1159/000544704
An Approach to the Bone Marrow Workup and Diagnosis of Eosinophilia and Mast Cell Disorders
Reichard, K. K., George, T. I., & Arber, D. A. (2025) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000486
Rüfer, A., Müllner, G., Fuchs, O., Sperr, W. R., & Hoermann, G. (2025) · Swiss Medical Weekly · doi:10.57187/s.3679
Self-citationHeigh, V. L., Reichard, K. K., & Mangaonkar, A. A. (2025) · American Journal of Hematology · doi:10.1002/ajh.27677
Hereditary alpha tryptasemia and clinical implications
Önata, E. T., Özdemır, Ö., & Savaşan, S. (2025) · World Journal of Clinical Cases · doi:10.12998/wjcc.v13.i21.104723
Hereditary alpha tryptasemia and food allergy
Lang, A. T. (2025) · Frontiers in Allergy · doi:10.3389/falgy.2025.1583462 · Cited by 1
Alheraky, A., van der Ley, C. P., van Faassen, M. H. J. R., Klein, S. K., Elberink, H. N. G. O., Roozendaal, C., Vos, M. J., Mulder, A. B., & Kema, I. P. (2025) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2025-0189
Jiang, M., & Vadas, P. (2025) · Canadian allergy & immunology today. · doi:10.58931/cait.2025.5179
Alfa triptazemijos aktualumas klinikinėje praktikoje
Šematonytė, J., Vaidotaitė, G., Vainoriūtė, G., & Traberg, R. (2025) · Pulmonology and allergology · doi:10.37499/pia.1699
Chen, D., & George, T. I. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-10940-9.00021-6
Diagnostic and prognostic utility of inflammatory biomarkers in dermatology: A narrative review
Sardesai, V. R., & Ojha, S. (2025) · Indian Journal of Dermatology Venereology and Leprology · doi:10.25259/ijdvl_350_2025
Alpha-triptasemia ereditaria: prevalenza e relazione tra copie di TPSAB1 e triptasi basale
Bruno, L., Onida, R., CATALANO, V., Barrale, M., Cantisano, V., MANCUSO, G. G., & Brusca, I. (2025) · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine · doi:10.23736/s1825-859x.25.00304-4
Polivka, L., Hermine, O., & Rossignol, J. (2025) · Frontiers in Allergy · doi:10.3389/falgy.2025.1674609 · Cited by 1
Platzgummer, S., SIPMeL, A. N. D. G.-A., Onida, R., Bruno, L., Caponi, L., Anzivino, P., Conte, M., ZANONI, G., Ghisellini, S., Deleonardi, G., et al. (2026) · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine · doi:10.23736/s1825-859x.25.00312-3
Stefanzl, G., Kopanja, S., Ivanov, D., Greiner, G., Hoermann, G., Arock, M., Szépfalusi, Z., Sperr, W. R., & Valent, P. (2026) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2026.02.008
Self-citationHereditary Alpha-Tryptasemia and Mastocytosis: What We Know and What We Need To Learn
Rama, T. A., & Gülen, T. (2026) · Current Allergy and Asthma Reports · doi:10.1007/s11882-026-01262-9 · Cited by 1
McMurray, J. C., Bingemann, T. A., & Golden, D. B. K. (2026) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2026.01.006
Koliofotis, F., Katrachoura, N., Papapostolou, N., Τaka, S., Martinou, M., Bouchla, A., Papageorgiou, S. G., & Makris, M. P. (2026) · Journal of Personalized Medicine · doi:10.3390/jpm16040196
Hereditary Alpha-Tryptasemia (HαT) as a Risk Modifier for Severe Anaphylaxis
Lang, A. T., Kazmi, W., & Lyons, J. J. (2026) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2026.01.010
Mast Cell Activation Syndrome and Mimickers
Ahn, C., Calle, C. A. G., & Bernstein, J. A. (2026) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2026.01.014
Premières étapes dans l'interaction hôte-pathogène : rôle de l'immunité locale et innée
Michel, M. (2022) · theses.fr (ABES) · doi:10.70675/4647f4d2zd802z40abza572z8ff228db523f
Simeone, I. M., Galeas‐Pena, M., White, K., Sullivan, B., Morelli, A., Silvester, J. A., Konnikova, L., Therrien, A., & Glover, S. C. (2026) · Frontiers in Allergy · doi:10.3389/falgy.2026.1783914 · Cited by 1
Modern approaches to the diagnosis of alpha-tryptasemia
Lisiecka, M. Z., & Luczak, J. (2026) · Journal of Applied Genetics · doi:10.1007/s13353-026-01062-x
Brockow, K., Franz, T. M., Saak, M., Lorenz, H., Plötz, J., Stark, L., Schäbitz, A., Aydin, G., Rupp, S., Untch, J., et al. (2026) · Allergo Journal International · doi:10.1007/s40629-026-00373-z
Extended multisystem manifestations of hereditary α-tryptasemia in an allergy center cohort
Koch, D., Wortmann, F., Recke, A., Rose, E., Gaffal, E., Wigger, J., von Bubnoff, N. C. C., & von Bubnoff, D. (2026) · Journal of Allergy and Clinical Immunology Global · doi:10.1016/j.jacig.2026.100737
Brockow, K., Franz, T. M., Saak, M., Lorenz, H., Plötz, J., Stark, L., Schäbitz, A., Aydin, G., Rupp, S., Untch, J., et al. (2026) · Allergo Journal · doi:10.1007/s15007-026-6701-x
Systemic Mastocytosis in Adults: 2026 Update on Diagnosis, Risk Stratification and Management
Pardanani, A. D. (2026) · American Journal of Hematology · doi:10.1002/ajh.70395
Le rhumatologue et le mastocyte
Nansion, M. (2026) · Revue du Rhumatisme · doi:10.1016/j.rhum.2026.06.038
AMICI, M. D., Taietti, I., Castagnoli, R., Bossi, G., Randazzese, S. F., Marseglia, A., Caimmi, S. M. E., & Licari, A. (2026) · Biomolecules · doi:10.3390/biom16091360
Svetina, M., Lyons, J. J., Kopač, P., Šelb, J., Košnik, M., Rijavec, M., & Korošec, P. (2026) · Clinical & Experimental Allergy · doi:10.1111/cea.70448
Editorial: Hereditary alpha-tryptasemia: 10 years on
Kačar, M., Kopač, P., & Lyons, J. J. (2026) · Frontiers in Allergy · doi:10.3389/falgy.2026.1980092
Hereditary α-tryptasemia is associated with response to omalizumab in severe allergic asthma
Rijavec, M., Svetina, M., Škrgat, S., Zidarn, M., Lyons, J. J., Šelb, J., Barber, C., Vorobeva, E., Haitchi, H. M., Graham, N. J., et al. (2026) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2026.10.014
Metadata
- Authors
- Greiner, G., Sprinzl, B., Górska, A., Ratzinger, F., Gurbisz, M., Witzeneder, N., Schmetterer, K. G., Gisslinger, B., Uyanik, G., Hadzijusufovic, E., Esterbauer, H., Gleixner, K. V., Krauth, M. T., Pfeilstöcker, M., Keil, F., Gisslinger, H., Nedoszytko, B., Niedoszytko, M., Sperr, W. R., Valent, P., & Hoermann, G.
- Affiliations
- Ludwig Boltzmann Institute for Hematology and Oncology (AT)
- Hanusch Hospital (AT)
- Gdańsk Medical University (PL)
- Ihr Labor, Medical Diagnostic Laboratories, Vienna, Austria;
- Medical University of Vienna (AT)
- Sigmund Freud Privatuniversität Wien (AT)
- University of Veterinary Medicine Vienna (AT)
- Department of Dermatology, Medical University of Gdańsk, Gdańsk, Poland;
- Innsbruck Medical University (AT)
- Corresponding author
- Hoermann, Gregor
- ORCID
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2021-01-14
- Volume
- 137
- Issue
- 2
- Pages
- 238-247
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC7116780
- OpenAlex
- W3048592971
- Cited by
- 189
- References
- 59
- Citations by year
- 2026: 24 · 2025: 31 · 2024: 28 · 2023: 29 · 2022: 33 · 2021: 40
- FWCI
- 9.18
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal Tumor Research and Treatment
- Health Sciences › Medicine › Surgery › Congenital gastrointestinal and neural anomalies
- Keywords
- hereditary alpha-tryptasemia, mastocytosis, TPSAB1, copy number gain, genetic biomarkers, anaphylaxis, KIT D816V mutation, mast cell activation, myeloid neoplasms
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Female, Genetic Markers, Humans, Male, Mastocytosis, Middle Aged, Tryptases, Young Adult, DNA Copy Number Variations
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
